Your browser doesn't support javascript.
loading
Two Cases of Viral Re-suppression After M184V + R263K Selection on Dolutegravir/Lamivudine Without Treatment Modification.
Ursenbach, Axel; Ruch, Yvon; Hoellinger, Baptiste; Fuchs, Anne; Caspar, Stéphanie; Jegou, Frédérick; Rey, David; Fafi-Kremer, Samira; Mesplède, Thibault; Gantner, Pierre.
Afiliação
  • Ursenbach A; Le Trait d'Union, HIV-Infection Care Center, Strasbourg University Hospital, Strasbourg, France.
  • Ruch Y; Infectious Diseases Department, Strasbourg University Hospital, Strasbourg, France.
  • Hoellinger B; Infectious Diseases Department, Strasbourg University Hospital, Strasbourg, France.
  • Fuchs A; Clinical Virology Laboratory, Strasbourg University Hospital, Strasbourg, France.
  • Caspar S; Clinical Virology Laboratory, Strasbourg University Hospital, Strasbourg, France.
  • Jegou F; Clinical Virology Laboratory, Strasbourg University Hospital, Strasbourg, France.
  • Rey D; Le Trait d'Union, HIV-Infection Care Center, Strasbourg University Hospital, Strasbourg, France.
  • Fafi-Kremer S; Clinical Virology Laboratory, Strasbourg University Hospital, Strasbourg, France.
  • Mesplède T; INSERM UMR_S1109, Strasbourg University, Strasbourg, France.
  • Gantner P; Viroscience Department, Erasmus Medical Center, Rotterdam, The Netherlands.
Clin Infect Dis ; 79(1): 198-201, 2024 Jul 19.
Article em En | MEDLINE | ID: mdl-38193816
ABSTRACT
Dolutegravir/lamivudine (DTG/3TC) has a high genetic barrier against the development of human immunodeficiency virus drug resistance. We report 2 cases of R263K + M184V mutations during DTG/3TC failure followed by viral suppression after adherence intervention without treatment change that we attribute to residual drug activity, reduced viral fitness, and robust immune competence.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxazinas / Piperazinas / Piridonas / Infecções por HIV / Lamivudina / Fármacos Anti-HIV / Farmacorresistência Viral / Compostos Heterocíclicos com 3 Anéis Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Infect Dis / Clin. infect. dis / Clinical infectious diseases Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxazinas / Piperazinas / Piridonas / Infecções por HIV / Lamivudina / Fármacos Anti-HIV / Farmacorresistência Viral / Compostos Heterocíclicos com 3 Anéis Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Infect Dis / Clin. infect. dis / Clinical infectious diseases Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: França